Interferon activation in primary Sjogren's syndrome: recent insights and future perspective as novel treatment target

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	817-829
Number of pages	13
Journal	Expert Review of Clinical Immunology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1080/1744666x.2018.1519396
Publication status	Published - 2018

Access to Document

@article{b7ccf2bf894f4716a43206d3229407d0,

title = "Interferon activation in primary Sjogren's syndrome: recent insights and future perspective as novel treatment target",

author = "Iris Bodewes and Marjan Versnel",

year = "2018",

doi = "10.1080/1744666x.2018.1519396",

language = "Undefined/Unknown",

volume = "14",

pages = "817--829",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Taylor and Francis Ltd.",

number = "10",

}

TY - JOUR

T1 - Interferon activation in primary Sjogren's syndrome: recent insights and future perspective as novel treatment target

AU - Bodewes, Iris

AU - Versnel, Marjan

PY - 2018

Y1 - 2018

U2 - 10.1080/1744666x.2018.1519396

DO - 10.1080/1744666x.2018.1519396

M3 - Article

VL - 14

SP - 817

EP - 829

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 10

ER -